Additionally, the data presented in this study further supports the role of EGRF and downstream MEK/ERK activation in the development of tissue fibrosis, as previous studies have correlated the activation of these pathways to IPF development[38,39]. Here, MAP2K7 is linked to idiopathic pulmonary fibrosis.